Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A Study in Participants With Type 2 Diabetes Mellitus
The Impact of LY2605541 Versus Insulin Glargine for Patients With Type 2 Diabetes Mellitus Advanced to Multiple Injection Bolus Insulin With Insulin Lispro: a Double-Blind, Randomized, 26-week Study - The IMAGINE 4 Study
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Seattle, WA
A Study in Participants With Type 2 Diabetes Mellitus
The Impact of LY2605541 Versus Insulin Glargine for Patients With Type 2 Diabetes Mellitus Advanced to Multiple Injection Bolus Insulin With Insulin Lispro: a Double-Blind, Randomized, 26-week Study - The IMAGINE 4 Study
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)
A Study to Assess the Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Encino, CA
Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)
A Study to Assess the Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Encino, CA
Click here to add this to my saved trials
A Clinical Study of the C8 MediSensors Optical Glucose Monitor™
A Clinical Study to Evaluate the Performance of the C8 MediSensors Optical Glucose Monitor™ During On-Site Testing and Real Time Use Monitoring
Status: Enrolling
Updated:  11/9/2012
C8 MediSensors, Inc.
mi
from
San Jose, CA
A Clinical Study of the C8 MediSensors Optical Glucose Monitor™
A Clinical Study to Evaluate the Performance of the C8 MediSensors Optical Glucose Monitor™ During On-Site Testing and Real Time Use Monitoring
Status: Enrolling
Updated: 11/9/2012
C8 MediSensors, Inc.
mi
from
San Jose, CA
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Chandler, AZ
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Chino, CA
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Norwalk, CA
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Norwalk, CA
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Simi Valley, CA
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Simi Valley, CA
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Atlanta, GA
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Aurora, IL
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Aurora, IL
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Owensboro, KY
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Owensboro, KY
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Baltimore, MD
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Springfield, MO
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Melville, NY
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Melville, NY
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Raleigh, NC
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Greensboro, NC
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Greensboro, NC
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Cincinnati, OH
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Willow Grove, PA
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Willow Grove, PA
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Charleston, SC
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Dallas, TX
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Houston, TX
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Plano, TX
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Plano, TX
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
San Antonio, TX
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
San Antonio, TX
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Bountiful, UT
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Bountiful, UT
Click here to add this to my saved trials
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated:  11/14/2012
Clinical Research Facility
mi
from
Renton, WA
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Renton, WA
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Birmingham, AL
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Walnut Creek, CA
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Aurora, CO
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Aurora, CO
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Washington,
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Jacksonville, FL
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Pinellas Park, FL
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Chicago, IL
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Baltimore, MD
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Worcester, MA
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Worcester, MA
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Kalamazoo, MI
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Minneapolis, MN
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Gulfport, MS
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Gulfport, MS
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Omaha, NE
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Omaha, NE
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Mentor, OH
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Mentor, OH
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Rapid City, SD
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Rapid City, SD
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
San Antonio, TX
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated:  11/15/2012
GSK Investigational Site
mi
from
Toronto,
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
Status: Enrolling
Updated: 11/15/2012
GSK Investigational Site
mi
from
Toronto,
Click here to add this to my saved trials
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated:  11/20/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated: 11/20/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated:  11/20/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated: 11/20/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated:  11/20/2012
Clinical Research Facility
mi
from
Overland Park, KA
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated: 11/20/2012
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated:  11/20/2012
Clinical Research Facility
mi
from
St. Joseph, MO
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated: 11/20/2012
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated:  11/20/2012
Clinical Research Facility
mi
from
New York, NY
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated: 11/20/2012
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated:  11/20/2012
Clinical Research Facility
mi
from
Ashville, NC
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated: 11/20/2012
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated:  11/20/2012
Clinical Research Facility
mi
from
Cleveland, OH
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
Status: Enrolling
Updated: 11/20/2012
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials